Congenital Myotonic Dystrophy
Information
- Disease name
- Congenital Myotonic Dystrophy
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03692312 | Completed | Phase 2/Phase 3 | Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy | March 3, 2021 | April 4, 2023 |
| NCT00082108 | Recruiting | Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry | September 2000 | June 2024 | |
| NCT02398786 | Recruiting | Myotonic Dystrophy Family Registry | February 2013 | February 2025 | |
| NCT03059264 | Recruiting | Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy | December 14, 2016 | July 15, 2024 | |
| NCT05004129 | Recruiting | Phase 2/Phase 3 | Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy | August 23, 2021 | March 28, 2025 |
| NCT05224778 | Recruiting | DMCRN-02-001: Assessing Pediatric Endpoints in DM1 | August 24, 2022 | December 2026 |
- MedGen concept unique identifier (MedGen Concept name)
- C0410226
- MedGen unique identifier (MedGen Concept name)
- 98051